Detailansicht

Wissensnetz

Person

Andreas Meid (1981-)

Pharmakologe

Name	Andreas Meid
Zeit	1981- (Lebensdaten)
Ort	Bruchsal (Geburtsort) Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	PD (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2022) Dr. sc. hum. (an der Medizinischen Fakultät Heidelberg der Ruprecht-Karls-Universität) (2017)
Beruf	Pharmakologe (charakteristischer Beruf)
Variante	Andreas D. Meid Andreas Daniel Meid
Beziehung	Klinikum Heidelberg (Abt. Klinische Pharmakologie und Pharmakoepidemiologie)
Datensatztyp	Person
GND-Nummer	1076301991
Datensatz-ID	1076301991
Beteiligt an alle anzeigen Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults HIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views Adhärenz bei kardiovaskulären Arzneimitteln in der Post-Hospitalphase : Assoziation mit klinischen Endpunkten und Vorhersage künftiger Adhärenz von direkten oralen Antikoagulantien in Abrechnungsdaten deutscher Krankenkassen Teaching reproducible research for medical students and postgraduate pharmaceutical scientists The impact of a computerized physician order entry system implementation on 20 different criteria of medication documentation—a before-and-after study Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis Are anticholinergic symptoms a risk factor for falls in older general practice patients with polypharmacy? Study protocol for the development and validation of a prognostic model Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients Health Service Use, Costs, and Adverse Events Associated with Potentially Inappropriate Medication in Old Age in Germany: Retrospective Matched Cohort Study How can we define and analyse drug exposure more precisely to improve the prediction of hospitalizations in longitudinal (claims) data? Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life Age-Dependent Impact of Medication Underuse and Strategies for Improvement Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Andreas Meid (1981-)

Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin

CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults

HIOPP-6 – a pilot study on the evaluation of an electronic tool to assess and reduce the complexity of drug treatment considering patients’ views

Adhärenz bei kardiovaskulären Arzneimitteln in der Post-Hospitalphase : Assoziation mit klinischen Endpunkten und Vorhersage künftiger Adhärenz von direkten oralen Antikoagulantien in Abrechnungsdaten deutscher Krankenkassen

Teaching reproducible research for medical students and postgraduate pharmaceutical scientists

The impact of a computerized physician order entry system implementation on 20 different criteria of medication documentation—a before-and-after study

Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis

Are anticholinergic symptoms a risk factor for falls in older general practice patients with polypharmacy? Study protocol for the development and validation of a prognostic model

Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity

Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity

Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity

Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice

Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients

Health Service Use, Costs, and Adverse Events Associated with Potentially Inappropriate Medication in Old Age in Germany: Retrospective Matched Cohort Study

How can we define and analyse drug exposure more precisely to improve the prediction of hospitalizations in longitudinal (claims) data?

Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data

Longitudinal evaluation of medication underuse in older outpatients and its association with quality of life

Age-Dependent Impact of Medication Underuse and Strategies for Improvement

Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria